[ad_1]
Apple could post free cash flow ahead of net income at a time when tech rivals’ heavy AI spending could prevent them from hitting that mark.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...